Skip to main content
. 2007 Mar 29;581(Pt 3):1001–1018. doi: 10.1113/jphysiol.2007.132886

Table 1.

Parameters obtained from fitting the Hill equation to GABA, β-alanine, taurine, I4AA, and 5α-THDOC data

GABAAR subtype EC50m) nH Imax (nA) n
GABA-dependent activation
 α6β2(1)δ 7
   High-affinity component 0.005 ± 0.001 1.16 ± 0.11 259.50 ± 73.96
   Low-affinity component 2.29 ± 0.85 0.56 ± 0.05  479.10 ± 123.94
  Low expression 2.62 ± 0.39 0.63 ± 0.02 129.06 ± 10.72 9
 Intermediate expression 0.46 ± 0.12 0.54 ± 0.02 317.39 ± 56.43 7
 High expression  0.04 ± 0.009 0.65 ± 0.04 690.60 ± 80.23 11
 α6β2(0.3)δ 1.52 ± 0.38 0.63 ± 0.03 362.80 ± 97.95 6
 α6β2(0.1)δ 1.25 ± 0.21 0.74 ± 0.02 321.67 ± 50.62 10
 α1β2(1)γ2S 2.87 ± 1.20 1.33 ± 0.10 2287.43 ± 237.76 7
 α1β2(0.4)γ2S 10.61 ± 3.27 1.22 ± 0.10 2270.33 ± 354.79 6
 α1β2(0.08)γ2S 37.20 ± 4.58 1.26 ± 0.14  974.33 ± 497.32 3
 α1β2δ 6.45 ± 0.85 1.14 ± 0.05 510.02 ± 80.43 9
 α6β2γ2S 22.30 ± 1.98 0.88 ± 0.14  484.00 ± 122.45 4
 α4β2δ 1.53 ± 0.14 0.85 ± 0.03 338.09 ± 52.61 11
 α6β2δR287M 3.71 ± 0.94 0.69 ± 0.18 44.67 ± 2.33 3
 α6βY157Fδ 13
   High-affinity component 0.37 ± 0.05 0.97 ± 0.04 355.54 ± 80.52
   High-affinity component 104.65 ± 28.04 0.85 ± 0.14 389.23 ± 63.43
 α6βY157F (0.1)δ 53.27 ± 13.99 0.94 ± 0.14 161.33 ± 36.99 3
I4AA-dependent activation
 α6β2δ 4
   High-affinity component 0.06 ± 0.01 0.82 ± 0.04 254.68 ± 52.02
   High-affinity component 202.25 ± 17.71 2.61 ± 0.44 183.41 ± 16.77
β-Alanine-dependent activation
 α6β2δ 5
   High-affinity component 1.16 ± 0.72 0.89 ± 0.12 160.61 ± 69.75
   High-affinity component 594.66 ± 142.86 0.67 ± 0.05 277.94 ± 64.02
 Low expression 412.14 ± 68.76 0.71 ± 0.03 302.74 ± 58.79 10
 Intermediate expression 111.86 ± 13.72 0.55 ± 0.15  426.33 ± 166.71 3
 High expression 2.56 ± 1.52 0.59 ± 0.16 945.00 ± 76.51 3
Taurine-dependent activation
 α6β2δ 3
   High-affinity component 5.80 ± 0.84 1.03 ± 0.05 225.33 ± 43.42
   High-affinity component 806.67 ± 193.50 0.91 ± 0.29 205.00 ± 40.31
 Low expression 1817.58 ± 865.99 0.69 ± 0.06 145.40 ± 13.31 4
 Intermediate expression 45.16 ± 25.57 0.55 ± 0.05 398.30 ± 63.92 3
 High expression 6.03 ± 1.62 0.90 ± 0.10  607.63 ± 160.86 4
5α-THDOC-dependent activation
 α6β2δ 0.89 ± 0.49 0.97 ± 0.06 550.67 ± 67.25 3
HHS Vulnerability Disclosure